Modification of tumor suppressor gene expression in non-small cell lung cancer (NSCLC) with a retroviral vector expressing wildtype (normal) p53

Human Gene Therapy

Volumn 7, Issue 7, 1996, Pages 861-874

  Roth, Jack A ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; EXPRESSION VECTOR; GENE EXPRESSION REGULATION; GENE THERAPY; HUMAN; LUNG NON SMALL CELL CANCER; ONCOGENE; RETROVIRUS; TUMOR SUPPRESSOR GENE; VIRUS REPLICATION;

EID: 0029968043     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1996.7.7-861     Document Type: Article

References (26)

1. Brown CC, Kessler LG. Projections of lung cancer mortality in the United States: 1985-2025. JNCI 1988; 80:43-51,
2. Bishop JM. Molecular themes in oncogenesis. Cell 1991; 64:235-248.
3. Santos E, Nebreda AR. Structural and functional properties of ras proteins. FASEB 1989; 3:2151-2163.
4. Shimizu K, Birnbaum D, Ruly MA, et al. Structure of the ki-ras gene of the human lung carcinoma cell line calu-1. Nature 1983; 304:497-500.
5. Rodenhuis S, Van De Wetering ML, Mooi WJ, Evers SG, Van Zandwijk N, Bos JL. Mutational activation of the K-ras oncogene. A possible pathogenetic factor in adenocarcinoma of the lung. N Engl J Med 1987; 317 (15):929-935.
6. Rodenhuis S, Slebos RJC, Boot AJM, et al. Incidence and possible clinical significance of K-ras oncogene activation in adenocarcinoma of the human lung. Cancer Res 1988; 48:5738-5741.
7. Reynolds SH, Anna CK, Brown KC, et al. Activated protooncogenes in human lung tumors from smokers. Proc Natl Acad Sci USA 1991; 88:1085-1089.
8. Hollstein M, Sidransky D, Vogelstein B, Harris CC. p53 mutations in human cancers. Science 1991; 253:49-53.
9. Lane DP, Benchimol S. p53: oncogene or anti-oncogene? Genes & Develop 1990; 4:1-8.
10. Bressac B, Calvin KM, Liang TJ, Isselbacher KJ, Wands JR. Abnormal structure and expression of p53 gene in human heptatocellular carcinoma. Proc Natl Acad Sci USA 1990; 87:1973-1977.
11. Dolcetti R, Maestro R, Feriotto G, Pelucchi S, Rizzo S, Boiocchi M. p53 genetic abnormalities in human squamous cell carcinomas of the larynx. Oncogene 1990; 6:44-45.
12. Rodrigues NR, Rowan A, Smith MEF, et al. p53 mutations in colorectal cancer. Proc Natl Acad Sci USA 1990; 87:7555-7559.
13. Nigro JM, Baker SJ, Preisinger AC, et al. Mutations in the p53 gene occur in diverse human tumor types. Nature 1989; 342:705-708.
14. Takahashi T, Nau MM, Chiba I, et al. p53: a frequent target f or genetic abnormalities in lung cancer. Science 1989; 246:491-494.
15. Mukhopadhyay T, Cavender A, Tainsky M, Roth JA. Expression of antisense K-ras message in a human lung cancer cell line with a spontaneous activated K-ras oncogene alters the transformed phenotype. Proc Amer Assoc Cancer Res 1990; 31:304.
16. Mukhopadhyay T, Cavender AC, Branch CD, Roth JA. Expression and regulation of wild type p53 gene (wtp53) in human non-small cell lung cancer (NSCLC) cell lines carrying normal or mutated p53 gene. J Cell Biochem 1991; Suppl 15F:22.
17. Soriano P, Montgomery C, Geske R, Bradley A. Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 1991; 64:693-702.
18. Chen P-L, Chen Y, Bookstein R, Lee W-H. Genetic mechanisms of tumor suppression by the human p53 gene. Science 1990; 250;1576-1580.
19. Humphrey EW, Smart CR, Winchester DP, et al. National survey of the pattern of care for carcinoma of the lung. J Thorac Cardiovasc Surg 1990; 100 (6):837-843.
20. Perez CA, Stanley K, Rubin P, et al. Patterns of tumor recurrence after definitive irradiation for inoperable non-oat cell carcinoma of the lung. Int J Radiat Oncol Biol Phys 1980; 6:987-994.
21. Komaki R, Garden AS, Cundiff JH. Endobronchial Radiotherapy. In: Roth JA, Hong WK, Cox JD, eds. Advances in Lung Cancer. Cambridge, MA: Blackwell Scientific Publications, Inc. 1992:
22. Miller AD, Rosman GJ. Improved retroviral vectors for gene transfer and expression. BioTechniques 1989; 7(9):980-990.
23. Palmer TD, Hock RA, Osborne WRA, Miller AD. Efficient retrovirus-mediated transfer and expression of a human adenosine deaminase gene in diplid skin fibroblasts from an adenosine deaminase-deficient human. Proc Natl Acad Sci USA 1987; 84: 1055-1059.
24. Markowitz D, Goff S, Bank A. Construction and use of a safe and efficient amphotropic packaging cell line. Virol 1988; 167: 400-406.
25. Casson AG, Mukhopadhyay T, Cleary KR, Ro JY, Levin B, Roth JA. p53 gene mutations in Barrett's epithelium and eosphageal cancer. Cancer Res 1991; 51:4495-4499.
26. Rosenberg SA, Kasid A, Anderson WF, et al. Human Gene Ther 1990; 1:443-462.